EMI2 expression as a poor prognostic factor in patients with breast cancer

EMI2 expression as a poor prognostic factor in patients with breast cancer

Abstract Early mitotic inhibitor 2 (EMI2, gene symbol FBXO43), an APC/C inhibitor regulated by Plx1, is essential for cytostatic factor (CSF) activity. It belongs to subclass FBXO of the F‐box proteins family. The aim of this study is to examine the clinicopathological significance of EMI2 in breast...

Full description

Bibliographic Details
Main Authors: Anupama Vadhan, Yen‐Yun Wang, Shyng‐Shiou F. Yuan, Yi‐Chen Lee, Stephen Chu‐Sung Hu, Jyun‐Yuan Huang, Takashi Ishikawa, Ming‐Feng Hou
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
breast cancer
EMI2 (FBXO43)
metastasis
Online Access:https://doi.org/10.1002/kjm2.12208

Similar Items

Similar Items